Double failure: the shared accountability of governments and firms for the innovation deficit in the pharmaceutical sector
Naci, Huseyin
; Carter, Alexander W.; and Mossialos, Elias
(2015)
Double failure: the shared accountability of governments and firms for the innovation deficit in the pharmaceutical sector
BMJ.
ISSN 1756-1833
Despite the large number of new medicines entering the market every year, the vast majority offer few clinical advantages for patients over existing alternatives. Governments and pharmaceutical companies share the responsibility for this innovation deficit in the sector
| Item Type | Article |
|---|---|
| Departments |
Social Policy LSE Health |
| Date Deposited | 29 Oct 2015 09:39 |
| URI | https://researchonline.lse.ac.uk/id/eprint/64215 |
-
picture_as_pdf -
subject - Accepted Version
-
lock - Restricted to Registered users only
Downloads
ORCID: https://orcid.org/0000-0002-7192-5751
ORCID: https://orcid.org/0000-0001-8664-9297